select

Innovative medical system is just what the doctor ordered

Posted on: 8/27/2016
Innovative medical system is just what the doctor ordered

Clinical web system developed in East Midlands after Technology Demonstration Grant is awarded to local company

An innovative web-based software system that could help health professionals across the UK and Europe manage treatment of prostate cancer, and other lower urinary tract symptoms, has been developed in the East Midlands, thanks to a technology Demonstration Grant from East Midlands Economics Online (EMEO).

The Clinical Decision Support System (CDSS) has successfully been piloted in Derby and Nottingham and has been commissioned by Derby City Primary Care Trust. The software helps healthcare professionals decide whether patients can continue to be safely treated in the community and when they need to see a hospital consultant.

The CDSS processes the patient’s symptoms and test results to enable professionals to safely determine when patients need to see a hospital consultant, and which cases can be more effectively monitored and treated by General Practitioners and nurses in the community. The system not only helps medical professionals to manage conditions, but also saves time and money.

It means that patients with less complex conditions do not have to make repeat trips to hospital, while consultants have more time to focus on and treat the most serious urological disorders.

Mr Mike Henley, consultant urologist for Derby Hospitals NHS Foundation Trust, headed up the collaborative project between the Trust and Mansfield-based companies iQudos Limited and MS3 Limited.

Speaking about the system, Fred Jacobs, the CEO of iQudos and MS3 Limited, said: “Consultants are still vital for diagnosing and treating patients. This type of innovation supports nursing staff to provide treatment and recommend disease management for the local GP, freeing up time for the hospital consultants to perform more complicated or urgent procedures.”

NHS Innovation East Midlands (the region’s NHS Innovation hub) helped form the partnership, which then developed and tested CDSS once a Technology Demonstration grant of £280,000 from EMEO had been secured as part of the Regional Technology Framework.

This grant was matched by Derby Hospitals NHS Foundation Trust. Additional support around regulatory affairs was provided by the Healthcare and Bioscience innovation Network (iNet), which is funded by the European Regional Development Fund and EMEO.

Mike Carr, EMEO’s Executive Director of Business Services, said: “The successful outcome and benefits of this project to healthcare patients, professionals and the region’s economy demonstrate the value of EMEO’s Demonstration grant scheme. It’s designed to capitalise on great ideas, from the straightforward to the highly sophisticated, in technology areas of key importance the East Midlands.

“This project also demonstrates the strength and collaborative activity of the Healthcare and Bioscience iNet, that operates in the East Midlands with EMEO and ERDF funding. Here, like minded organisations, such as these businesses, the NHS and its Innovation Hub, have worked together to achieve significant economic success.”

Dr Carl Edwards, CEO of NHS Innovation East Midlands, said: “There has never been a more important time to support this sort of clinical innovation within the NHS. The staff of the NHS have the ideas that can transform healthcare, but they need the support of the right organisations like the Hub to make things happen.”

iQudos’ contribution to the project was also shortlisted for the ‘Partnership with the NHS’ prize at Medilink East Midlands’ 2016 Innovation Day awards ceremony, which took place at Derby’s Pride Park in April. The CDSS narrowly missed out to eventual category winner Leicester-based Renfrew Group International.

Following successful trialling of the software in Derby and Nottingham, CDSS is due to be rolled out across 250,000 patients this summer. The online software has also been approved for use as a medical device across the European Union, and it will be used in the management of other long-term care diseases.

For more information about other business support that is available, contact Business Link on 0845 058 6644, or visit www.businesslink.gov.uk/eastmidlands

For more information, visit: www.EMEO.org.uk

Share |
 
News and events > Single Item